Meningiomas are among the most common brain tumors. Their incidence is about 1%, and they account for almost one third of all primary intracranial masses. The majority of meningiomas are very slowly growing and nonsymptomatic or minimally symptomatic entities, discovered as incidental findings on neuroimaging [@bb0005]. The World Health Organization (WHO) classification system distinguishes 3 histological grades and 15 subtypes and is a well-accepted tool for prediction of prognosis. Although most meningiomas are benign masses, certain histological subtypes reveal very high recurrence rates despite the tumors' seemingly total removal. Grade II (atypical) and grade III (anaplastic) meningiomas are associated with an increased risk of recurrence, are more aggressive, and show invasive behavior [@bb0010]. Grade I meningiomas are generally considered as benign tumors, but recent studies indicate substantial neurological deficits and impaired long-term survival due to tumor recurrence and stroke despite their low histopathological grading in a considerable proportion of cases [@bb0015], [@bb0020]. Increased mitotic activity (more than 4 mitoses per 10 high-power fields) and elevated Ki-67 expression (Ki-67 index of more than 5% of nuclei) are reliable histopathological markers for tumor recurrence [@bb0010].

Because histopathological grading alone does not predict outcome satisfyingly, numerous studies investigated the value of preoperative magnetic resonance imaging (MRI) for prognostics. For example, Liu et al. demonstrated that hyperintensity on diffusion-weighted imaging, heterogeneous gadolinium enhancement, disruption of the arachnoid at brain tumor interface, T2 hyperintense peritumoral edema, and irregular tumor shape were independent predictors of non--grade I meningioma [@bb0025]. Other works produced comparable results, although some of these studies underline the importance of positive capsular enhancement [@bb0030], [@bb0035], whereas others emphasize the predictive value of peritumoral edema [@bb0025], [@bb0040]. All the above-cited works investigated morphological features of meningiomas summarized in subjective scoring systems, but not one of the studies objectively analyzed values of SIs in commonly used preoperative MRI sequences.

Therefore, the aim of this study was to investigate the predictive value of genuine and normalized SIs of standardized preoperative MRI (T1 pre- and postcontrast, T2, and fluid-attenuated inversion recovery \[FLAIR\]) as *in vivo* predictors of proliferative activity of meningiomas.

Material and Methods {#s0010}
====================

This study was approved by the institutional review board (Martin Luther University Ethics Committee).

Patients {#s0030}
--------

Overall, 66 patients with different meningiomas were included into the retrospective analysis. There were 50 women and 16 men with a mean age of 59.7 ± 15.8 years. In 56 patients (approximately 84.8%), WHO grade I tumors were diagnosed. Most frequently, meningothelial meningiomas (*n* = 32,) followed by transitional (*n* = 12), fibroblastic (*n* = 7), angiomatous (*n* = 4), and psammomatous (*n* = 1) subtypes were identified. Grade II tumors were identified in 9 cases (13.6%) and grade III in 1 (1.5%).

MRI {#s0035}
---

In all patients, cranial MRI was performed using a 1.5-T device (Magnetom Vision Sonata Upgrade, Siemens, Erlangen, Germany). The imaging protocol included the following sequences:1.Axial T2-weighted (T2w) fluid-attenuated inversion recovery (FLAIR) sequence (repetition time/echo time: 8000/129, slice thickness: 5 mm, acquisition matrix: 256 × 256, field of view: 230 mm);2.Axial and coronal T1-weighted (T1w) spin echo sequences (repetition time/echo time: 562/16, slice thickness: 5 mm, acquisition matrix: 256 × 256, field of view: 230 mm) before and after intravenous application of contrast medium (gadopentate dimeglumine, Magnevist, Bayer Schering Pharma, Leverkusen, Germany).

All images were available in digital form and were analyzed by one radiologist (A. S., 14 years of radiological experience) on a PACS workstation (Centricity PACS, GE Medical Systems, Milwaukee, WI).

The slices with the largest diameter of each tumor were selected for signal intensity (SI) calculation. In every case, a polygonal region of interest (ROI) as large as possible was manually drawn on postcontrast T1w images. Every ROI was automatically placed also on all other images (T2w and precontrast T1w). Cystic and necrotic areas as well as large vessels of the tumors were not considered for evaluation. In all images, mean SI values were estimated. Furthermore, ROIs were drawn in the normal white matter of the contralateral hemisphere (SI white matter). Normalized SI was calculated in every case as the ratio SI meningioma/SI white matter. In addition, for each lesion, the ratio SI on postcontrast T1w/SI on precontrast T1w was calculated (SI contrast). [Figure 1](#f0005){ref-type="fig"}, [Figure 2](#f0010){ref-type="fig"}, *a--c*, exemplarily show axial images (FLAIR, T1 precontrast, T1 postcontrast) of WHO grade I (transitional) and WHO grade II (atypical) meningiomas.

Histopathology and Immunohistochemistry {#s0040}
---------------------------------------

All included meningiomas were surgically resected and histopathologically analyzed. Tumor grading was classified according to the WHO [@bb0010].

In every case, the proliferation index was estimated on Ki-67 antigen-stained specimens by using MIB-1 monoclonal antibody (DakoCytomation, Denmark) as reported previously [@bb0045]. Two high-power fields (0.16 mm^2^ per field, × 400) were analyzed. The area with the highest number of positive tumor nuclei was selected. [Figures 1](#f0005){ref-type="fig"}*d* and 2*d* exemplarily show Ki-67 immunostaining of WHO grade I (transitional) and WHO grade II (atypical) meningiomas.

Statistical Analysis {#s0045}
--------------------

Statistical analysis was performed using SPSS Version 22. Differences between groups were assessed using one-way analysis of variance. Correlations between Ki-67 expression and genuine or normalized SIs, respectively, were calculated using a Spearman rho correlation. Significance level was set to .05.

Results {#s0015}
=======

MR SIs (T1 precontrast, FLAIR, T1 postcontrast, and normalized SIs) of the investigated grade I to III meningiomas and Ki-67 expression (%) are shown in [Table 1](#t0005){ref-type="table"}.

One-way analysis of variance did not show significant differences between meningiomas of WHO grade I, II, or III regarding their MRI SIs. The difference in Ki-67 expression achieved statistical significance (*P* \< .01) between low-grade and high-grade meningiomas. [Figure 3](#f0015){ref-type="fig"}, *a--h*, summarize the relation of MRI SIs and Ki-67 expression between WHO grade I and WHO grade II/III meningiomas. For reasons of simplicity and clarity, high-grade meningiomas (grade II and III meningiomas) are displayed together and compared with grade I meningiomas.

No correlation was found between MRI SIs and Ki-67 expression. [Table 2](#t0010){ref-type="table"} displays results of statistical analysis of the correlation between SIs (genuine and normalized) and Ki-67 expression.

Discussion {#s0020}
==========

We investigated in meningiomas the relationship between objectively measurable SIs on standard preoperative MRI and the proliferative activity in histopathology. Expression of the proliferation associated antigen Ki-67 was significantly higher in grade II and III meningiomas, but there was neither a significant difference of MRI SIs among grade I, II, or III meningiomas nor a correlation between Ki-67 expression and MRI SIs.

Preoperative MRI is a valuable tool for identification and follow-up of meningiomas with aggressive behavior in the clinical routine. High-grade meningiomas are a significant cause of morbidity and mortality and need to be identified prior to surgery to achieve the best resection. Numerous studies investigated morphological features of meningiomas in MRI to identify *in vivo* attributes that predict invasiveness and increased risk of recurrence [@bb0025], [@bb0030], [@bb0035], [@bb0040], [@bb0050], [@bb0055]. Consensually, peritumoral edema, ill-defined tumor margins, heterogeneous contrast enhancement, and absence of a subarachnoidal rim surrounding the tumor are important indicators of non--grade I meningiomas with aggressive tumor growth, high recurrence risk, and a tendency of infiltration of surrounding parenchyma. Nevertheless, these are subjective criteria only describing morphological features. Interobserver and intraobserver variability significantly reduces the reliability of these prediction models [@bb0030]. Previously, few studies investigated imaging parameters semiquantitatively and their relationship to histopathological features with at least partially contradictory findings. In earlier years Maiuri and coworkers [@bb0060] analyzed T1 and T2 SIs (clinically applied as categories of hypointensity, isointensity, and hyperintensity) in meningiomas and found that T1w images may predict the presence of cysts and intratumoral blood vessels, whereas T2w images may be able to give information about histological subtype, vascularity, and consistency. More recently, Hadidy and colleagues examined the association between SI on T1w and T2w FLAIR MRI (with very approximate categories of hypointensity, isointensity, and hyperintensity) as well as contrast enhancement patterns and histopathological grading [@bb0065] and found no correlation between MRI and histopathology. Besides these studies, other authors investigated the association between cellularity, Ki-67 expression, and different apparent diffusion coefficient fractions in low-grade and high-grade meningiomas and were able to show that apparent diffusion coefficient mean is able to distinguish between grade I and grade II/III meningiomas [@bb0070]. To the best of our knowledge, no further studies exist that investigated the correlation between objectively measurable, numeric MRI SIs and histopathological features, especially Ki-67 expression representing proliferative activity.

This study clarifies that even numerically quantified SIs of meningiomas in preoperative MRI cannot distinguish between low-grade, noninvasive meningiomas and high-grade, aggressive-invasive meningiomas.

Our work suffers some limitations. Firstly, it is of retrospective nature, and secondly, the number of analyzed high-grade meningiomas is comparatively small.

Conclusion {#s0025}
==========

To optimize surgical therapy, it is necessary to identify aggressive and invasive meningiomas on preoperative MRI. Numerous subjective scoring systems have been developed on the basis of morphological features of meningiomas in MRI to separate high-grade from low-grade meningiomas with varying sensitivities. This is the first study that investigated the value of objectively measured, quantified SIs as predictors of aggressive tumor behavior. Counterintuitively, quantitatively measured SIs of standardized preoperative MRI were not able to differentiate low -from high-grade meningiomas or to identify meningiomas with a high proliferative activity.
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![(a--d) Imaging findings (FLAIR, T1 precontrast, T1 postcontrast) and Ki-67 staining of a WHO grade I meningioma. Signal intensities were as follows: normalized FLAIR SI = 1.47, normalized precontrast T1 SI = 0.81, normalized postcontrast SI = 1.77, and postcontrast SI/precontrast SI = 2.24. Ki-67 index = 3%.](gr1){#f0005}

![(a--d) Imaging findings (FLAIR, T1precontrast, T1 postcontrast) and Ki-67 staining of a WHO grade II (atypical) meningioma. Signal intensities were as follows: normalized FLAIR SI = 1.45, normalized T1 precontrast SI = 0.87, normalized postcontrast SI = 1.88, and postcontrast SI/precontrast SI = 1.97. Ki-67 index = 18%.](gr2){#f0010}

![(a--h) Box plots give an overview on the relation of MRI SI (a--g) and Ki-67 index between low-grade and high-grade meningiomas.](gr3){#f0015}

###### 

MRI SIs Displayed as Genuine and Normalized Values (SI of the Respective Meningioma‚ m', Divided by the SI of the Unaffected Contralateral White Matter ‚wm') and Ki-67 Expression of All Investigated Meningiomas

  ------------------------------------------------------------------
                                 Mean ± SD       Median   Range
  ------------------------------ --------------- -------- ----------
  T1 meningioma                  332.8 ± 67.9    324      197-500

  T1 white matter                407.2 ± 63.5    411      276-600

  T1 m/wm                        0.8 ± 0.1       0.8      0.6-1.0

  FLAIR meningioma               323.9 ± 59      317      200-495

  FLAIR white matter             211.5 ± 26.8    210      145-285

  FLAIR m/wm                     1.5 ± 0.3       1.5      1.0-2.5

  T1 postcontrast meningioma     768.5 ± 165.3   764      512-1300

  T1 postcontrast white matter   407.7 ± 67.6    413.5    256-630

  T1 pos contrast m/wm           1.9 ± 0.4       1.9      1.1-2.9

  T1 [postcontrast m/wm]{.ul}\   2.3 ± 0.4       2.3      1.7-3.5
  T1 native m/wm                                          

  Ki-67 expression %             5.2 ± 5.3       3        1-20
  ------------------------------------------------------------------

###### 

Statistical Correlations between Genuine and Normalized SIs of Meningioma and Ki-67 Expression

  ---------------------------------------------------------------------------------------------------------------------------
            T1 m           T 1 m/wm         FLAIR m         FLAIR m/wm     T1 pc m         T1 pc m/wm       T1 pc/T1 native
  --------- -------------- ---------------- --------------- -------------- --------------- ---------------- -----------------
  Ki-67 %   *r* = − 0.9\   *r* = − 0.186\   *r* = − 0.48\   *r* = 0.002\   *r* = − 0.99\   *r* = − 0.109\   *r* = 0.029\
            *P* = − .489   *P* = .152       *P* = .723      *P* = .991     *P* = .439      *P* = .396       *P* = .827

  ---------------------------------------------------------------------------------------------------------------------------
